Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-03084014 in AIDS-associated Kaposi Sarcoma
NCT02137564Phase 2Withdrawn
- Sponsor
- AIDS Malignancy Consortium
- Start
- Jul 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of nirogacestat in Kaposi sarcoma (KS), sponsored by AIDS Malignancy Consortium. Planned start Jul 2015; status: withdrawn.
02
Drugs
nirogacestat
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT02137564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137564.